After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, VRDN falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Viridian Therapeutics Inc is $1.50B. A total of 0.9 million shares were traded on the day, compared to an average of 1.36M shares.
In the most recent transaction, Beetham Thomas W. bought 5,000 shares of VRDN for 23.41 per share on Sep 27 ’24. After the transaction, the Chief Operating Officer now owns 6,000 company shares. In a previous transaction on Sep 27 ’24, Mahoney Stephen F. bought 21,400 shares at 23.33 per share. VRDN shares that President and CEO owns now total 21,400.
Among the insiders who bought shares, Fairmount Funds Management LLC acquired of 1,600,000 shares on Sep 13 ’24 at a per-share price of $18.75. This resulted in the Director holding 3,445,813 shares of VRDN after the transaction.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, VRDN has a high of $27.20 and a low of $11.40.
As of this writing, VRDN has an earnings estimate of -$1.0 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.7 per share and a lower estimate of -$1.15.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. VRDN’s latest balance sheet shows that the firm has $196.97M in Cash & Short Term Investments as of fiscal 2021. There were $520.00k in debt and $13.64M in liabilities at the time. Its Book Value Per Share was $6.55, while its Total Shareholder’s Equity was $187.72M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRDN is Buy with a score of 4.63.
